{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T08:46:33Z","timestamp":1785833193306,"version":"3.56.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12543-x","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T08:18:00Z","timestamp":1785831480000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Expression of wild-type and recombinant D4-CK domains of VWF gene with novel variants in Pakistan"],"prefix":"10.1007","volume":"53","author":[{"given":"Arshia","family":"Latif","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Asif","family":"Naveed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. A.","family":"Shabana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,4]]},"reference":[{"issue":"1","key":"12543_CR1","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41572-024-00536-8","volume":"10","author":"O Seidizadeh","year":"2024","unstructured":"Seidizadeh O et al (2024) von Willebrand disease. Nat Reviews Disease Primers 10(1):51. https:\/\/doi.org\/10.1038\/s41572-024-00536-8","journal-title":"Nat Reviews Disease Primers"},{"issue":"8","key":"12543_CR2","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.1016\/j.jtha.2025.04.029","volume":"23","author":"RK Friedman","year":"2025","unstructured":"Friedman RK et al (2025) Genetic study of von Willebrand factor antigen levels\u2009\u2264\u200950 IU\/dL identifies variants associated with increased risk of von Willebrand disease and bleeding. J Thromb Haemost 23(8):2410\u20132421. https:\/\/doi.org\/10.1016\/j.jtha.2025.04.029","journal-title":"J Thromb Haemost"},{"issue":"12","key":"12543_CR3","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1182\/blood.2023021915","volume":"144","author":"F Atiq","year":"2024","unstructured":"Atiq F, O\u2019Donnell JS (2024) Novel functions for Von Willebrand factor. Blood 144(12):1247\u20131256. https:\/\/doi.org\/10.1182\/blood.2023021915","journal-title":"Blood"},{"issue":"21","key":"12543_CR4","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.1182\/blood.2023023277","volume":"144","author":"PJ Lenting","year":"2024","unstructured":"Lenting PJ, Denis CV, Christophe OD (2024) How unique structural adaptations support and coordinate the complex function of von Willebrand factor. Blood 144(21):2174\u20132184. https:\/\/doi.org\/10.1182\/blood.2023023277","journal-title":"Blood"},{"issue":"1","key":"12543_CR5","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3324\/haematol.2024.286029","volume":"111","author":"SL Haberichter","year":"2026","unstructured":"Haberichter SL, O\u2019Donnell JS (2026) Structure and multiple functions of von Willebrand factor. Haematologica 111(1):15\u201325. https:\/\/doi.org\/10.3324\/haematol.2024.286029","journal-title":"Haematologica"},{"issue":"2","key":"12543_CR6","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1182\/blood-2012-01-405134","volume":"120","author":"Y-F Zhou","year":"2012","unstructured":"Zhou Y-F et al (2012) Sequence and structure relationships within von Willebrand factor. Blood. J Am Soc Hematol 120(2):449\u2013458. https:\/\/doi.org\/10.1182\/blood-2012-01-405134","journal-title":"J Am Soc Hematol"},{"issue":"1","key":"12543_CR7","doi-asserted-by":"publisher","first-page":"44","DOI":"10.3324\/haematol.2024.286014","volume":"111","author":"O Seidizadeh","year":"2026","unstructured":"Seidizadeh O, Lillicrap D (2026) Molecular genetic testing in von Willebrand disease: past, present, and beyond. Haematologica 111(1):44. https:\/\/doi.org\/10.3324\/haematol.2024.286014","journal-title":"Haematologica"},{"issue":"4","key":"12543_CR8","doi-asserted-by":"publisher","first-page":"313","DOI":"10.5505\/tjh.2012.39205","volume":"29","author":"E Berber","year":"2012","unstructured":"Berber E (2012) The molecular genetics of von Willebrand disease. Turkish J Haematol 29(4):313. https:\/\/doi.org\/10.5505\/tjh.2012.39205","journal-title":"Turkish J Haematol"},{"issue":"1","key":"12543_CR9","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/s41421-022-00378-2","volume":"8","author":"Z Shu","year":"2022","unstructured":"Shu Z et al (2022) Structural mechanism of VWF D\u2019D3 dimer formation. Cell Discovery 8(1):14. https:\/\/doi.org\/10.1038\/s41421-022-00378-2","journal-title":"Cell Discovery"},{"issue":"9","key":"12543_CR10","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1182\/blood-2015-04-641902","volume":"127","author":"S Lippok","year":"2016","unstructured":"Lippok S et al (2016) von Willebrand factor is dimerized by protein disulfide isomerase. Blood. J Am Soc Hematol 127(9):1183\u20131191. https:\/\/doi.org\/10.1182\/blood-2015-04-641902","journal-title":"J Am Soc Hematol"},{"issue":"22","key":"12543_CR11","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1182\/blood.2021014729","volume":"139","author":"J Zeng","year":"2022","unstructured":"Zeng J et al (2022) Structural basis of von Willebrand factor multimerization and tubular storage. Blood. J Am Soc Hematol 139(22):3314\u20133324. https:\/\/doi.org\/10.1182\/blood.2021014729","journal-title":"J Am Soc Hematol"},{"key":"12543_CR12","doi-asserted-by":"publisher","unstructured":"Fang J et al (2025) Key residues regulating von Willebrand factor A1\/A2 interactions: insights from molecular dynamics simulations and experimental validation. Res Pract Thromb Haemostasis 9(8). https:\/\/doi.org\/10.1016\/j.rpth.2025.103267","DOI":"10.1016\/j.rpth.2025.103267"},{"issue":"7","key":"12543_CR13","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1111\/jth.15717","volume":"20","author":"M Kubo","year":"2022","unstructured":"Kubo M et al (2022) Increased cleavage of von Willebrand factor by ADAMTS13 may contribute strongly to acquired von Willebrand syndrome development in patients with essential thrombocythemia. J Thromb Haemost 20(7):1589\u20131598. https:\/\/doi.org\/10.1111\/jth.15717","journal-title":"J Thromb Haemost"},{"key":"12543_CR14","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.thromres.2023.06.024","volume":"229","author":"J Lin","year":"2023","unstructured":"Lin J et al (2023) Force-induced biphasic regulation of VWF cleavage by ADAMTS13. Thromb Res 229:99\u2013106. https:\/\/doi.org\/10.1016\/j.thromres.2023.06.024","journal-title":"Thromb Res"},{"issue":"07","key":"12543_CR15","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1055\/s-0039-1687878","volume":"119","author":"G K\u00f6nig","year":"2019","unstructured":"K\u00f6nig G et al (2019) Alteration in GPIIb\/IIIa binding of VWD-associated von Willebrand factor variants with C-terminal missense mutations. Thromb Haemost 119(07):1102\u20131111. https:\/\/doi.org\/10.1055\/s-0039-1687878","journal-title":"Thromb Haemost"},{"issue":"04","key":"12543_CR16","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1055\/a-2186-6362","volume":"124","author":"O Seidizadeh","year":"2024","unstructured":"Seidizadeh O et al (2024) Clinical and laboratory presentation and underlying mechanism in patients with low VWF. Thromb Haemost 124(04):340\u2013350. https:\/\/doi.org\/10.1055\/a-2186-6362","journal-title":"Thromb Haemost"},{"issue":"1","key":"12543_CR17","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1182\/bloodadvances.2020003265","volume":"5","author":"PD James","year":"2021","unstructured":"James PD et al (2021) ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease. Blood Adv 5(1):280\u2013300. https:\/\/doi.org\/10.1182\/bloodadvances.2020003265","journal-title":"Blood Adv"},{"issue":"2","key":"12543_CR18","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1182\/blood-2002-12-3693","volume":"102","author":"LA O\u2019Brien","year":"2003","unstructured":"O\u2019Brien LA et al (2003) Founder von Willebrand factor haplotype associated with type 1 von Willebrand disease. Blood 102(2):549\u2013557. https:\/\/doi.org\/10.1182\/blood-2002-12-3693","journal-title":"Blood"},{"issue":"1","key":"12543_CR19","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3324\/haematol.2024.286058","volume":"111","author":"G Castaman","year":"2026","unstructured":"Castaman G, Federici AB (2026) Von Willebrand disease: classification and epidemiology. Haematologica 111(1):26. https:\/\/doi.org\/10.3324\/haematol.2024.286058","journal-title":"Haematologica"},{"issue":"2","key":"12543_CR20","doi-asserted-by":"publisher","first-page":"609","DOI":"10.3324\/haematol.2025.288342","volume":"111","author":"O Seidizadeh","year":"2025","unstructured":"Seidizadeh O et al (2025) Genetic determinants of clinical variability in type 2 von Willebrand disease: bridging genotype and phenotype. Haematologica 111(2):609. https:\/\/doi.org\/10.3324\/haematol.2025.288342","journal-title":"Haematologica"},{"issue":"12","key":"12543_CR21","doi-asserted-by":"publisher","first-page":"6366","DOI":"10.1016\/j.ymthe.2025.09.027","volume":"33","author":"Z Zhang","year":"2025","unstructured":"Zhang Z et al (2025) Correction of VWF multimerization in type 2A\/IIC von Willebrand disease by exogenous VWF propeptide supplementation. Mol Ther 33(12):6366\u20136378. https:\/\/doi.org\/10.1016\/j.ymthe.2025.09.027","journal-title":"Mol Ther"},{"key":"12543_CR22","doi-asserted-by":"publisher","first-page":"107602962614227","DOI":"10.1177\/10760296261422757","volume":"32","author":"M Borhany","year":"2026","unstructured":"Borhany M et al (2026) Clinical Spectrum, Subtype Distribution, and Treatment Outcomes in von Willebrand Disease: A Prospective Study from a Hemophilia Treatment Center in Pakistan. Clin Appl Thromb Hemost 32:10760296261422757. https:\/\/doi.org\/10.1177\/10760296261422757","journal-title":"Clin Appl Thromb Hemost"},{"issue":"6","key":"12543_CR23","doi-asserted-by":"publisher","first-page":"971","DOI":"10.3390\/genes13060971","volume":"13","author":"MA Naveed","year":"2022","unstructured":"Naveed MA et al (2022) Genetic alterations, DNA methylation, alloantibodies and phenotypic heterogeneity in Type III von Willebrand Disease. Genes 13(6):971. https:\/\/doi.org\/10.3390\/genes13060971","journal-title":"Genes"},{"issue":"2","key":"12543_CR24","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.devcel.2005.12.012","volume":"10","author":"G Michaux","year":"2006","unstructured":"Michaux G et al (2006) The physiological function of von Willebrand\u2019s factor depends on its tubular storage in endothelial Weibel-Palade bodies. Dev Cell 10(2):223\u2013232. https:\/\/doi.org\/10.1016\/j.devcel.2005.12.012","journal-title":"Dev Cell"},{"issue":"10","key":"12543_CR25","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1111\/j.1538-7836.2009.03551.x","volume":"7","author":"E Berber","year":"2009","unstructured":"Berber E et al (2009) An assessment of the pathogenic significance of the R924Q von Willebrand factor substitution. J Thromb Haemost 7(10):1672\u20131679. https:\/\/doi.org\/10.1111\/j.1538-7836.2009.03551.x","journal-title":"J Thromb Haemost"},{"issue":"1","key":"12543_CR26","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/MBC.0b013e32834cb35d","volume":"23","author":"MI Hassan","year":"2012","unstructured":"Hassan MI, Saxena A, Ahmad F (2012) Structure and function of von Willebrand factor. Blood Coagul Fibrinolysis 23(1):11\u201322. https:\/\/doi.org\/10.1097\/MBC.0b013e32834cb35d","journal-title":"Blood Coagul Fibrinolysis"},{"key":"12543_CR27","doi-asserted-by":"publisher","unstructured":"Montgomery RR, Flood VH, Haberichter SL (2024) von Willebrand factor structure and function. Textbook of von Willebrand disease: basic and clinical aspects 23\u201338. https:\/\/doi.org\/10.1002\/9781119419525.ch3","DOI":"10.1002\/9781119419525.ch3"},{"issue":"23","key":"12543_CR28","doi-asserted-by":"publisher","first-page":"9226","DOI":"10.1073\/pnas.0903679106","volume":"106","author":"Q Zhang","year":"2009","unstructured":"Zhang Q (2009) Structural specializations of A2, a force-sensing domain in the ultralarge vascular protein von Willebrand factor. Proc Nat Acad Sci 106(23):9226\u20139231. https:\/\/doi.org\/10.1073\/pnas.0903679106","journal-title":"Proc Nat Acad Sci"},{"issue":"14","key":"12543_CR29","doi-asserted-by":"publisher","first-page":"5760","DOI":"10.1074\/jbc.M117.776732","volume":"292","author":"K South","year":"2017","unstructured":"South K, Freitas MO, Lane DA (2017) A model for the conformational activation of the structurally quiescent metalloprotease ADAMTS13 by von Willebrand factor. J Biol Chem 292(14):5760\u20135769. https:\/\/doi.org\/10.1074\/jbc.M117.776732","journal-title":"J Biol Chem"},{"issue":"13","key":"12543_CR30","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.1182\/blood-2009-05-224915","volume":"114","author":"S Zanardelli","year":"2009","unstructured":"Zanardelli S et al (2009) A novel binding site for ADAMTS13 constitutively exposed on the surface of globular VWF. J Am Soc Hematol 114(13):2819\u20132828. https:\/\/doi.org\/10.1182\/blood-2009-05-224915. Blood","journal-title":"J Am Soc Hematol"},{"issue":"3","key":"12543_CR31","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.jtha.2022.11.022","volume":"21","author":"SJ Choi","year":"2023","unstructured":"Choi SJ et al (2023) The mechanistic and structural role of von Willebrand factor in endotoxemia-enhanced deep vein thrombosis in mice. J Thromb Haemost 21(3):586\u2013598. https:\/\/doi.org\/10.1016\/j.jtha.2022.11.022","journal-title":"J Thromb Haemost"},{"issue":"1","key":"12543_CR32","doi-asserted-by":"publisher","first-page":"13","DOI":"10.4103\/jasmr.jasmr_35_22","volume":"18","author":"A Haffouz","year":"2023","unstructured":"Haffouz A, Gargouri A, Hadjkacem B (2023) Antiplatelet agents: an overview. J Arab Soc Med Res 18(1):13\u201325. https:\/\/doi.org\/10.4103\/jasmr.jasmr_35_22","journal-title":"J Arab Soc Med Res"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12543-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12543-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12543-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T08:18:00Z","timestamp":1785831480000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12543-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,4]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12543"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12543-x","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,4]]},"assertion":[{"value":"21 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by Department of Microbiology and Molecular Genetics Research Ethics and Biosafety Committee, University of the Punjab, Pakistan (Approval No. D\/27\/3\u201320\/MMG). Human Embryonic Kidney cells (HEK293T) were used for the expression analysis of VWF protein.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. No human participants were involved in this study; only established human embryonic cell lines were used for in vitro experiments.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Consent to Publish","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1336"}}